Xcout Intel
Debiopharm competitors & alternatives
The 12 closest competitors and alternatives to Debiopharm among biotech companies — ranked by similarity to what Debiopharm actually does, not by market-cap band.
Subscribe to see Debiopharm’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Debiopharm
Debiopharm is an independent biopharmaceutical company based in Switzerland that develops treatments for oncology and infectious diseases. The company focuses on drug development, drug manufacturing, and strategic investments in digital health and smart data start-ups.
Debiopharm at a glance
Debiopharm is a biotech company headquartered in Switzerland. Xcout tracks 7 named people at Debiopharm, including Bertrand Ducrey (Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm). Xcout recorded 8 job postings from Debiopharm in the last 90 days.
Debiopharm leadership
- Bertrand DucreyChief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm
- Angela ZubelChief Development Officer, Research & Development
- Frederic LevyChief Scientific Officer, Search & Evaluation and Scientific Innovation
- Nicolas FavreChief Business Officer, Business Development & Commercial
- Pierre JullianChief Finance Officer, Finance, HR, IT & Administration
- Vanessa CurratChief Legal Officer, Legal Affairs, Intellectual Property & Pre-Commercial Alliances
1 more named person on record for Debiopharm, with roles, board committees and tenure — see the full roster →
Hiring at Debiopharm
Xcout recorded 8 job postings from Debiopharm in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Debiopharm's hiring signals →
Top 12 Debiopharm competitors
Ranked by semantic similarity — how close each company is to Debiopharm by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
D3 Bio is a biopharmaceutical company headquartered in Shanghai, China, focused on the discovery and development of innovative oncology and immunology medicines.
Biotechnology
Oncomatryx is a Spanish biopharmaceutical company headquartered in Derio, Basque Country, Spain. The firm pioneers targeted oncology therapeutics aimed at treating metastatic solid tumors and utilizes advanced computational approaches in its drug discovery pipeline.
Similar biotech company
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Biotechnology
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Biotechnology
BioVersys AG is an award-winning, privately-owned Swiss pharmaceutical and biotech company headquartered in Basel, Switzerland, focused on the research and development of antibacterial treatments for drug-resistant bacterial infections.
Similar biotech company
Philogen is a Swiss-Italian biotechnology company that focuses on the research, development, and commercialization of targeted therapeutics for the treatment of cancer and other serious conditions. The company utilizes proprietary antibody-based technologies to develop biopharmaceuticals, immunotherapies, and radio-conjugates for oncology and imaging applications.
Similar biotech company
Deka Biosciences, Inc. is an early-stage biotechnology holding company located in Germantown, Maryland, focused on developing and delivering life-changing medicines for cancer patients.
Similar biotech company
Numab Therapeutics is a Swiss biotechnology company developing multispecific antibody-based medicines that modulate immune-cell interactions. Its programs target serious diseases including cancer and immune-mediated or inflammatory disorders, serving patients through development and potential partnerships with pharmaceutical companies.
Similar biotech company
Polpharma Biologics is a biotechnology company that develops and manufactures biosimilar medicines to improve patient access to biopharmaceuticals. Operating from Switzerland, the company manages a broad portfolio of biosimilars targeting major therapeutic areas and collaborates with global biopharmaceutical partners to bring these treatments from concept to commercial supply.
Biotechnology
Artios Pharma is an independent biotechnology company headquartered at the Babraham Research Campus in Cambridge, United Kingdom, focused on discovering novel cancer therapies through DNA damage response mechanisms.
Biotechnology
Step Pharma is a clinical-stage pharmaceutical company focused on developing novel targeted therapies, notably involving CTPS1 inhibitors for treating various indications. Headquartered in France, the company is backed by a syndicate of international investors.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Debiopharm and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Debiopharmand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →